Cathepsin G Available to Researchers at Lee Biosolutions

ST. LOUIS – Cathepsin G from human neutrophils is now available to clinical research professionals from Lee Biosolutions at LeeBio.com.

Cathepsin G is a serine protease implicated in cytokine release, receptor activation, and degradation of tissue proteins. Poor regulation of Cathepsin G levels has been associated with a number of connective tissue disorders, including pulmonary emphysema and cystic fibrosis.

According to Lee Biosolutions President Burton Lee, Cathepsin G is just one of a number of new products the company is phasing into production.

“We aim to always stay ahead of the game and anticipate researcher demand before it happens,” Lee said, “We’re constantly out to maintain a reputation for versatility in our services and consistency in our product.”

Lee Biosolutions offers human neutrophil Cathepsin G in both liquid and lyophilized forms. The company also has biotinylated human neutrophil Cathepsin G for sale.

Cathepsin G is bactericidal, and contributes to the digestion of bacteria by polymorphonuclear leukocytes. Research suggests that neutrophils auto-regulate their lytic efficiency by controlling the exocytosis of primary granules via Cathepsin G activity.

Lee Biosolutions is a leader in the biomaterials industry, providing the quality biomaterial products to clinical labs and researchers around the world, developing tomorrow’s cures. The company has provided the materials used in a number of high profile biomarker studies. For more information or to place an order, contact Lee Biosolutions at 314-968-1091, or visit the company’s newly redesigned website, www.leebio.com.